Common use of Amendments or Supplements; Issuer Free Writing Prospectus Clause in Contracts

Amendments or Supplements; Issuer Free Writing Prospectus. Before using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Representatives reasonably object.

Appears in 2 contracts

Samples: Intra-Cellular Therapies, Inc., Intra-Cellular Therapies, Inc.

AutoNDA by SimpleDocs

Amendments or Supplements; Issuer Free Writing Prospectus. Before preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package Statement or the Prospectus, the Company will furnish to the Representatives Representative and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Representatives Representative reasonably object.objects. DRAFT

Appears in 1 contract

Samples: Masisa S.A.

AutoNDA by SimpleDocs

Amendments or Supplements; Issuer Free Writing Prospectus. Before using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package Statement or the Prospectus, the Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Representatives reasonably object.

Appears in 1 contract

Samples: Intra-Cellular Therapies, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.